Managed care
The Kirkland Family Medical Center, PA
The Kirkland Family Medical Center, PA was paid $715K by Medicaid between Jan 2018 and Nov 2024, across 35 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoTHE KIRKLAND FAMILY MEDICAL CENTER, PA
DARDANELLE, AR 72834
DARDANELLE, AR 72834
33aNPI1316145022assigned 07/03/2007
33bProvider typePreferred Provider Organization
28Total paid$715K
24GClaims45,001
24DCodes billed35
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Preferred Provider Organization providers in Arkansas
Rank by total paid#3 of 7
Median peer was paid$229K
This provider vs. median3.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,483 | $73K | |
| 2019 | 2,738 | $83K | |
| 2020 | 1,902 | $63K | |
| 2021 | 4,013 | $108K | |
| 2022 | 11,168 | $167K | |
| 2023 | 13,957 | $138K | |
| 2024incomplete | 8,740 | $82K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 8,695 | 7,714 | $275K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 4,422 | 3,917 | $254K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 10% | 621 | 572 | $72K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.1% | 711 | 679 | $36K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.1% | 454 | 435 | $22K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.3% | 257 | 210 | $17K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 580 | 547 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 827 | 790 | $10K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.1% | 62 | 62 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 154 | 140 | $5K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 169 | 101 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 79 | 78 | $1K |
23 more codes
| 96127 | <1% | 214 | $664.31 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 13 | $592.30 |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 13 | $303.15 |
| 99307 | <1% | 12 | $121.83 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 40 | $109.73 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $83.22 |
| 36415 | Collection of venous blood by venipuncture | <1% | 55 | $61.45 |
| 1126F | <1% | 3,528 | $33.41 | |
| 81003 | <1% | 57 | $32.00 | |
| 1034F | <1% | 141 | $28.12 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13 | $27.26 |
| 1125F | <1% | 2,199 | $24.40 | |
| 1036F | <1% | 1,330 | $21.71 | |
| 3075F | <1% | 511 | $20.00 | |
| 3079F | <1% | 1,115 | $20.00 | |
| 3078F | <1% | 4,879 | $0.06 | |
| 3074F | <1% | 5,333 | $0.06 | |
| 1159F | <1% | 5,239 | $0.05 | |
| 3008F | <1% | 2,195 | $0.04 | |
| 1160F | <1% | 961 | $0.03 | |
| 3077F | 0% | 47 | $0.00 | |
| 3725F | 0% | 51 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKIRKLAND, ALLAN (PRESIDENT)